Skip to main content

Table 2 Response to the postoperative pain after discharge

From: Effect of Dinalbuphine sebacate on postoperative multimodal analgesic strategy in video-assisted thoracoscopic surgery: a double-blind randomized controlled trial

 

Placebo (n = 29)

DS (n = 28)

p value

Were you currently experiencing pain associated with this surgery?

 - POW1 (yes/no)

28/1 (97)

24/4 (86)

0.1936

 - POM1 (yes/no)

26/3 (90)

6/22 (21)

< 0.001

Did the current pain interfere with your daily life?

 - POW1 (yes/no)

25/4 (86)

8/20 (29)

< 0.001

 - POM1 (yes/no)

14/15 (48)

3/25 (11)

0.003

Pain intensity at rest (NRS)

- POW1

1.7 ± 0.5

0.4 ± 0.3

< 0.001

- POM1

0.3 ± 0.2

0.1 ± 0.1

0.07

Pain intensity with movement (NRS)

- POW1

4.0 ± 0.6

2.1 ± 0.6

< 0.001

- POM1

2.1 ± 0.4

0.6 ± 0.4

< 0.001

  1. Data are presented as mean ± SD or number (proportion). DS, Dinalbuphine Sebacate; POW, postoperative week; POM, postoperative month; NRS, numerical rating scale